NLM Logo

Ipilimumab MeSH Descriptor Data 2022


MeSH Heading
Ipilimumab
Tree Number(s)
D12.776.124.486.485.114.224.060.798
D12.776.124.790.651.114.224.060.798
D12.776.377.715.548.114.224.200.798
Unique ID
D000074324
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000074324
Scope Note
An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.
Entry Term(s)
Anti-CTLA-4 MAb Ipilimumab
MDX 010
MDX-010
MDX-CTLA-4
MDX010
Yervoy
Pharm Action
Antineoplastic Agents, Immunological
Immune Checkpoint Inhibitors
Registry Number
0
Related Numbers
6T8C155666
See Also
CTLA-4 Antigen
Public MeSH Note
2018; IPILIMUMAB was indexed under ANTIBODIES, MONOCLONAL, 2012-2017
History Note
2018(2012)
Date Established
2018/01/01
Date of Entry
2017/07/11
Revision Date
2020/02/28
Ipilimumab Preferred
Yervoy Narrower
MDX 010 Narrower
MDX-CTLA-4 Narrower
page delivered in 0.145s